{"version":"1.0","provider_name":"Scl\u00e9rodermie Qu\u00e9bec","provider_url":"https:\/\/sclerodermie.ca\/en\/","author_name":"sclero","author_url":"https:\/\/sclerodermie.ca\/en\/author\/sclero\/","title":"News - Scl\u00e9rodermie Qu\u00e9bec","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"LiFXsRpWJG\"><a href=\"https:\/\/sclerodermie.ca\/en\/news\/news\/\">News<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/sclerodermie.ca\/en\/news\/news\/embed\/#?secret=LiFXsRpWJG\" width=\"600\" height=\"338\" title=\"&#8220;News&#8221; &#8212; Scl\u00e9rodermie Qu\u00e9bec\" data-secret=\"LiFXsRpWJG\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/sclerodermie.ca\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"WINREVAIR\u00ae (sotatercept) is now authorized for use in Canada for Adults with Pulmonary Arterial Hypertension KIRKLAND, QC, September 4, 2024 \u2013 Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that WINREVAIR\u00ae (sotatercept) is now authorized for use in Canada in combination with standard pulmonary arterial hypertension (PAH) therapy, for [&hellip;]","thumbnail_url":"https:\/\/sclerodermie.ca\/wp-content\/uploads\/2020\/06\/ANG_SCLQ02_moisSclerodermie_facebook_couverture_851x315.jpg"}